Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
10/29/2013 | US8569232 Therapeutic agent for diabetes |
10/29/2013 | US8569231 Soluble non-depot insulin conjugates and uses thereof |
10/29/2013 | US8568805 Cognitive function |
10/29/2013 | US8568792 Metal compounds, mixed or sulphated, as phosphate binders |
10/29/2013 | CA2589483C Substituted piperazines as cb1 antagonists |
10/29/2013 | CA2544965C Heat moisture treated starch for the treatment of hypoglycaemia |
10/29/2013 | CA2529268C Pharmaceutical formulations of amyloid inhibiting compounds |
10/29/2013 | CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels |
10/29/2013 | CA2396992C Hybrid cells |
10/24/2013 | WO2013159006A1 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione |
10/24/2013 | WO2013158952A1 Isoindolone derivatives |
10/24/2013 | WO2013158874A1 Methods of producing anamorelin hydrochloride having controlled chloride content |
10/24/2013 | WO2013158868A1 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation |
10/24/2013 | WO2013158616A1 Treatment of medium-chain acyl-coa dehydrogenase deficiency |
10/24/2013 | WO2013157833A1 Composition including beta-blocker as an active principle for treating or improving obesity, metabolic diseases, and osteopenia |
10/24/2013 | WO2013157792A1 Bicyclic heteroaryl derivative and pharmaceutical composition comprising same |
10/24/2013 | WO2013157511A1 Arylaminopyrazole derivative |
10/24/2013 | WO2013156413A1 Methods of treating lactose intolerance |
10/24/2013 | WO2013155997A1 Blood lipid-regulating red yeast ligusticum chuanxiong pharmaceutical composition and preparation method therefor |
10/24/2013 | WO2013155996A1 Blood lipid-regulating red yeast curcuma zedoaria pharmaceutical composition and preparation method therefor |
10/24/2013 | WO2013155995A1 Red yeast and kudzu root pharmaceutical composition for regulating blood lipids and preparation method therefor |
10/24/2013 | WO2013155994A1 Red yeast and evening primrose pharmaceutical composition for regulating blood lipids and preparation method therefor |
10/24/2013 | WO2013155993A1 Red yeast and alisma pharmaceutical composition for regulating blood lipids and method of preparation thereof |
10/24/2013 | WO2013155741A1 Liuweidihuang liquid pill |
10/24/2013 | WO2013155739A1 Application of pigeon pea ketonic acid a in preparation of medicine for diabetes-accompanying disease and hyperlipidemia |
10/24/2013 | WO2013155600A1 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors |
10/24/2013 | WO2013125970A3 Dry concentrate for refreshing beverages suitable for people with diabetes and people on reduction diet and production process thereof |
10/24/2013 | WO2013022846A3 Flavonoid compounds |
10/24/2013 | US20130281705 Compounds for the treatment of metabolic disorders |
10/24/2013 | US20130281522 Methods for alzheimer's disease treatment and cognitive enhancement |
10/24/2013 | US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
10/24/2013 | US20130281419 Therapeutic Uses for an Aminosterol Compound |
10/24/2013 | US20130281418 Use of hydroxypregnenolone derivatives for enhancing health and physical performance |
10/24/2013 | US20130281416 Pharmaceutical composition |
10/24/2013 | US20130280330 Microsphere drug carrier, preparation method, composition and use thereof |
10/24/2013 | US20130280304 Method of administration of active agents to non-human mammals |
10/23/2013 | EP2653165A1 Hops oxidation product, and production method and use therefor |
10/23/2013 | EP2653158A1 Therapeutic agent for blood-brain barrier disruption syndrome |
10/23/2013 | EP2653157A1 Astaxanthin for improving muscle atrophy |
10/23/2013 | EP2653156A1 Pharmaceutical emulsion composition and use thereof |
10/23/2013 | EP2653041A1 Oxidation reaction product of hop extract, process for production thereof, and use thereof |
10/23/2013 | EP2652137A1 Lar protein-specific ligand |
10/23/2013 | EP2651970A1 Serum amyloid p protein |
10/23/2013 | EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases |
10/23/2013 | EP2651915A1 Continuous arycyclic compound |
10/23/2013 | EP2651446A1 Preparation comprising insulin, nicotinamide and an amino acid |
10/23/2013 | EP2651432A1 Fast-acting insulin in combination with long-acting insulin |
10/23/2013 | EP2651426A2 Proteins that stimulate the secretion of satiety hormones |
10/23/2013 | EP2651422A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof |
10/23/2013 | EP2651398A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
10/23/2013 | EP2651389A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them |
10/23/2013 | EP2651251A1 Composition for the treatment of metabolic disorders |
10/23/2013 | CN103370338A Myomegalin variant 8 and uses thereof |
10/23/2013 | CN103370307A Sulphonamide compounds and methods of making and using same |
10/23/2013 | CN103361202A Perfumed soap with belly slimming function |
10/23/2013 | CN103360428A Ruthenium-containing complex for inhibiting protein tyrosine phosphatase 1B activity as well as preparation method of complex and protein tyrosine phosphatase 1B inhibitor |
10/23/2013 | CN103360388A 5-Amino-1,4-dihydro-1,8-naphthyridine derivatives and pharmaceutical compositions as well as uses thereof |
10/23/2013 | CN103360276A Crystal form, preparation method and application of agomelatine, as well as medicine composition |
10/23/2013 | CN103360240A Preparation method of high purity fenofibric acid |
10/23/2013 | CN103356993A Application of collagen peptide in preparation of blood lipid lowering medicaments and health-care products |
10/23/2013 | CN103356971A Traditional Chinese medicine composition capable of substantially improving human immunity and preparation method thereof |
10/23/2013 | CN103356955A Chinese medicinal formula for treating hepatic glycogen storage disease |
10/23/2013 | CN103356921A Traditional Chinese medicine composition for treating and conditioning sub-health condition |
10/23/2013 | CN103356898A Capsule for treating diabetic retinopathy syndrome |
10/23/2013 | CN103356885A Medicine for treating diabetes |
10/23/2013 | CN103356860A Amla weight-losing capsule |
10/23/2013 | CN103356844A Chitosan oligosaccharide compound preparation and application thereof to preparation of drugs for treating skin diseases |
10/23/2013 | CN103356810A Extracting method of novel antioxidant of tea flowers |
10/23/2013 | CN103356730A Injection for increasing long-distance survival rate and healthy rate of young domestic fowls, and preparation method thereof |
10/23/2013 | CN103356687A Use of ivermectin and its derivative |
10/23/2013 | CN103356665A Application of new mangiferin to prevention and treatment of diabetic nephropathy |
10/23/2013 | CN103356661A Novel capsule filled with metformin hydrochloride solid preparation and glipizide solid preparation |
10/23/2013 | CN103356623A Novel ferrous fumarate and folic acid compound capsule |
10/23/2013 | CN103356621A Novel capsule filled with alogliptin solid preparation and pioglitazone solid preparation |
10/23/2013 | CN103356617A Application of deacetylase inhibitors in preparation of medicaments for promoting insulin secretion |
10/23/2013 | CN103356615A Tablet capsule filled with repaglinide tablet and metformin tablet |
10/23/2013 | CN103356611A Application of berberine in preparation of weight-loss drug |
10/23/2013 | CN103356593A Application of Chukrasone B in preparation of medicines for promoting insulin secretion |
10/23/2013 | CN103356592A Application of Chukrasone B in preparation medicines for reducing blood glucose |
10/23/2013 | CN103356565A Application of Sarcaboside B in preparation of drug for promoting insulin secretion |
10/23/2013 | CN103356540A Application of Sarcaboside A in medicine for promoting insulin secretion |
10/23/2013 | CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes |
10/23/2013 | CN103356507A Preparation method of all-trans tretinoin solid lipid nanoparticles |
10/23/2013 | CN103356502A Novel capsule filled with rosiglitazone solid preparation and metformin solid preparation |
10/23/2013 | CN103356500A Calcium rosuvastatin and fenofibric acid choline salt time-selecting osmotic pump controlled release tablet and preparation method thereof |
10/23/2013 | CN103356496A Citric acid calcium malate drug tablet |
10/23/2013 | CN103356494A High-stability simvastatin tablets and preparation method thereof |
10/23/2013 | CN103356486A Preparation method of fenofibrate and pravastatin sodium compound preparation |
10/23/2013 | CN103355844A Weight-losing insole |
10/23/2013 | CN103355668A Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
10/23/2013 | CN103355666A Preparation method of plant enzyme beverage capable of improving cardiovascular and cerebrovascular metabolic functions |
10/23/2013 | CN103355665A Composition for regulation of blood sugar level and adjunctive treatment of diabetes mellitus |
10/23/2013 | CN102872045B Application of gypensapogenin A to hypoglycemic drugs |
10/23/2013 | CN102757880B Maca health-care wine and preparation method thereof |
10/23/2013 | CN102702092B Eutectic of two curcumin organic medicaments and preparation method thereof |
10/23/2013 | CN102633873B Peptide, applications and preparation method thereof |
10/23/2013 | CN102579956B Medicament composition and application thereof |
10/23/2013 | CN102552696B Compound diabetes oral preparation and preparation method thereof |
10/23/2013 | CN102504046B Amphipathy polyethylene glycol stem grafting chitosan copolymer and preparation method and application thereof |
10/23/2013 | CN102451465B Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction |